一种基于高效率的催化循环放大策略的敏感电化学免疫传感器,用于检测心脏中特罗素I
Feng Jiang1, Yaoyao Meng1, Mengxiao Mo1
1School of Chemistry and Chemical Engineering, Shandong University of Technology, Zibo 255049, PR China.
Bioelectrochemistry (Amsterdam, Netherlands)
|May 19, 2024
概括
一个新的电化学免疫传感器使用催化循环放大策略来检测敏感的心脏素I (cTnI). 这种新的方法为潜在的生物标志物分析提供了高效率和低检测极限.
科学领域:
- 电化学 电化学 电化学
- 纳米材料科学 科学 纳米材料科学
- 生物医学工程 生物医学工程
背景情况:
- 心脏素I (cTnI) 是诊断心肌梗塞的一个关键生物标志物.
- 对cTnI的敏感和快速检测方法对于早期临床诊断至关重要.
- 现有的检测方法在灵敏度,特异性和成本效益方面面临挑战.
研究的目的:
- 开发一种新型的电化学免疫传感器,用于高度敏感的心脏素I (cTnI) 检测.
- 研究使用Cu2O/CuO@CeO2纳米混合的高效催化循环放大策略.
- 阐明用于增强信号放大的电化学机制和催化循环.
主要方法:
- 一种Cu2O/CuO@CeO2纳米混合物的制造,具有棘状黄体结构.
- 电化学表征用于研究电子转移和催化机制.
- 动不动的抗体用于cTnI的捕获.
- 使用循环电压测量和电压测量对cTnI进行电化学检测.
主要成果:
- 这种Cu2O/CuO@CeO2纳米混合体表现出了出色的电化学性能和电荷移动性.
- 实现了Cu和Ce物种的持续氧化还原循环,产生了新的活性位点.
- 开发的免疫传感器在广泛范围 (100 fg/mL至100 ng/mL) 中检测到cTnI,检测极限低 (15.85 fg/mL).
结论:
- 新的催化循环放大策略显著提高了检测灵敏度.
- 基于Cu2O/CuO@CeO2纳米混合的免疫传感器显示出对cTnI检测有很大的前景.
- 这种方法有可能对其他重要的生物标志物的敏感检测具有潜力.
更多相关视频
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
16.7K
08:58Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood
Published on: April 16, 2016
10.6K
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
138
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
138
Enzyme-Linked Immunosorbent Assay
12.9K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
12.9K
